Literature DB >> 17899519

[Guide to the comprehensive treatment of spasticity].

F Vivancos-Matellano1, S I Pascual-Pascual, J Nardi-Vilardaga, F Miquel-Rodriguez, I de Miguel-Leon, M C Martinez-Garre, I Martinez-Caballero, G Lanzas-Melendo, R Garreta-Figuera, P J Garcia-Ruiz, M Garcia-Bach, V Garcia-Aymerich, I Bori-Fortuny, M Aguilar-Barbera.   

Abstract

AIMS AND DEVELOPMENT: Spasticity is an important medical problem with a high rate of incidence both in childhood, mainly as a result of cerebral palsy, and in adults, which is frequently brought about by traumatic brain injuries, strokes and spinal cord injuries. Spasticity is part of upper motoneuron syndrome, which gives rise to important problems, such as limited joint movement, abnormal postures that can produce pain, impaired functional capacity, aesthetic or hygiene disorders, among others. It progresses naturally towards chronicity, accompanied by static phenomena due to alterations affecting the properties of soft tissues (elasticity, plasticity and viscosity). Numerous therapeutic options are available for the treatment of spasticity, including medication, physiotherapy, orthopaedic aid, surgery, and so forth. Moreover, treatment should be individualised and realistic, with goals that have been agreed between the patient or caregiver and the medical team. The aim of the following guide is to further our knowledge of this condition, its causes, epidemiology and progression, as well as to outline an approach that is both rational and global from the point of view of pharmacological, rehabilitation and surgical treatment.
CONCLUSIONS: Spasticity is a complex problem that requires specialists (neurologist, rehabilitation doctor, occupational therapist, orthopaedic surgeon, general practitioner, etc.) to work as a team in order to achieve the goals set out when treatment is begun. Early treatment is important to avoid or reduce, as far as possible, the severe complications stemming from this condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899519

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  5 in total

1.  Effects of dry needling on muscle spasticity of the upper limb in a survivor of traumatic brain injury: a case report.

Authors:  Najmeh Sedighimehr; Saber Zafarshamspour; Mohammadhassan Sadeghi
Journal:  J Med Case Rep       Date:  2022-06-14

2.  Experience in neuromuscular diseases in children and adolescents and their comorbidities in a tertiary hospital.

Authors:  J A Gascón-Navarro; J Torres-Borrego; M J De La Torre-Aguilar; J A Fernández-Ramos; J L Pérez-Navero
Journal:  Ital J Pediatr       Date:  2021-11-16       Impact factor: 2.638

Review 3.  Invasive Physiotherapy as a Treatment of Spasticity: A Systematic Review.

Authors:  Alberto Javier-Ormazábal; Montserrat González-Platas; Elena González-Sierra; Marta González-Sierra
Journal:  Degener Neurol Neuromuscul Dis       Date:  2022-03-03

Review 4.  Spasticity in multiple sclerosis and role of glatiramer acetate treatment.

Authors:  Jose Eustasio Meca-Lallana; Rocío Hernández-Clares; Ester Carreón-Guarnizo
Journal:  Brain Behav       Date:  2015-07-14       Impact factor: 2.708

Review 5.  Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity.

Authors:  Adán Pérez-Arredondo; Eduardo Cázares-Ramírez; Paul Carrillo-Mora; Marina Martínez-Vargas; Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Radamés Alemón-Medina; Aristides Sampieri; Luz Navarro; Liliana Carmona-Aparicio
Journal:  Clin Neuropharmacol       Date:  2016 Nov/Dec       Impact factor: 1.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.